Lupin Limited announced that Ms. Christine Mundkur, Independent Director will be stepping down from the Board of Directors of the Company, effective January 1, 2023, to avoid any conflict of interest since she has recently joined the Board of Cardinal Health, USA as an Independent Director.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,820 INR | -1.35% | +0.15% | +37.53% |
Jul. 16 | Lupin Sells US Commercial Women's Health Specialty Business to Evofem Biosciences | MT |
Jul. 15 | Lupin Gets Establishment Inspection Report from US FDA After Dabhasa Unit, Inspection | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.53% | 10.06B | |
+55.35% | 815B | |
+31.93% | 597B | |
-0.10% | 377B | |
+15.47% | 319B | |
+13.10% | 310B | |
+16.47% | 247B | |
+14.49% | 228B | |
+16.54% | 180B | |
+4.31% | 170B |
- Stock Market
- Equities
- LUPIN Stock
- News Lupin Limited
- Lupin Limited Announces Christine Mundkur Steps Down from Board of Directors, Effective January 1, 2023